Inosin pranobex (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inosin pranobex" in Czech language version.

refsWebsite

Global rank Czech rank

64nih.gov

4^th place

8^th place

40worldcat.org

5^th place

3^rd place

32doi.org

2^nd place

4^th place

8web.archive.org

1^st place

3practicus.eu

low place

2cancer.org

3,680^th place

2,061^st place

2sukl.cz

low place

373^rd place

2tribune.cz

low place

2,003^rd place

1medicines.org.uk

3,823^rd place

low place

1remedia.cz

low place

2,835^th place

1medikamio.com

low place

1neosine.pl

low place

1patents.google.com

1,182^nd place

1,958^th place

1medicaljournals.se

low place

1asm.org

3,555^th place

1,232^nd place

1lww.com

2,769^th place

1,842^nd place

1clinicaltrials.gov

5,225^th place

2,661^st place

1wiley.com

222^nd place

83^rd place

1who.int

195^th place

168^th place

1cochranelibrary.com

low place

3,607^th place

1indiatimes.com

17^th place

803^rd place

1theprint.in

987^th place

low place

1precisionvaccinations.com

low place

1ockovacicentrum.cz

low place

5,934^th place

1mdpi.com

2,912^th place

482^nd place

1aktualne.cz

2,459^th place

13^th place

1forbes.cz

low place

124^th place

1zdravotnickydenik.cz

low place

1,824^th place

1frekvence1.cz

low place

737^th place

1petice.com

low place

3,698^th place

1prolekare.cz

low place

2,870^th place

1google.cz

low place

390^th place

1nature.com

234^th place

72^nd place

1oncologia.mx

low place

aktualne.cz

zpravy.aktualne.cz

PRUŽINOVÁ, Kristýna. Opravdu pomáhá, píšou lidé o isoprinosinu. K pochybám ale stačí jediný argument. Aktuálně.cz [online]. Economia, 2021-03-09 [cit. 2021-03-09]. Dostupné online.

asm.org

aac.asm.org

KOVACS, J. A.; POWELL, F.; VOELLER, D. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.. Antimicrobial Agents and Chemotherapy. 1993-06-01, roč. 37, čís. 6, s. 1227–1231. PMID 7687120. Dostupné online [cit. 2021-03-13]. ISSN 0066-4804. DOI 10.1128/AAC.37.6.1227. PMID 7687120. (anglicky) Archivováno 28. 10. 2020 na Wayback Machine.

cancer.org

AMERICAN CANCER SOCIETY. Inosine Pranobex [online]. [cit. 2013-07-31]. Dostupné v archivu pořízeném z originálu dne 23 August 2010.
Inosine Pranobex. web.archive.org [online]. 2010-08-23 [cit. 2021-03-13]. Dostupné v archivu pořízeném z originálu dne 2010-08-23.

clinicaltrials.gov

National Library of Medicine: 10 Studies found for: Isoprinosine, 4.12.2021

cochranelibrary.com

CTRI/2021/02/030892. A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the defined standard of Care in Covid patients. https://trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/02/030892. 2021-03-31. Dostupné online [cit. 2022-03-16]. DOI 10.1002/central/CN-02241419. (anglicky)

doi.org

dx.doi.org

Campoli-Richards DM, Sorkin EM, Heel RC. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. Nov 1986, s. 383–424. DOI 10.2165/00003495-198632050-00001.
CAMPOLI-RICHARDS, Deborah M.; SORKIN, Eugene M.; HEEL, Rennie C. Inosine Pranobex. Drugs. 1986-11-01, roč. 32, čís. 5, s. 383–424. Dostupné online [cit. 2021-03-27]. ISSN 1179-1950. DOI 10.2165/00003495-198632050-00001. (anglicky)
SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 08 2019, roč. 36, čís. 8, s. 1878–1905. PMID 31168764 PMCID: PMC6822865. Dostupné online [cit. 2021-03-10]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764.
Inosiplex for Treatment of Alopecia Areata: a Randomized Placebo-controlled Study. www.medicaljournals.se [online]. [cit. 2021-03-13]. DOI: 10.2340/00015555-0138. Dostupné online. DOI 10.2340/00015555-0138.
KOVACS, J. A.; POWELL, F.; VOELLER, D. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.. Antimicrobial Agents and Chemotherapy. 1993-06-01, roč. 37, čís. 6, s. 1227–1231. PMID 7687120. Dostupné online [cit. 2021-03-13]. ISSN 0066-4804. DOI 10.1128/AAC.37.6.1227. PMID 7687120. (anglicky) Archivováno 28. 10. 2020 na Wayback Machine.
DE SIMONE, C.; FAMULARO, G.; TZANTZOGLOU, S. Inosine pranobex in the treatment of HIV infection: a review. International Journal of Immunopharmacology. 1991, roč. 13 Suppl 1, s. 19–27. PMID 1726683. Dostupné online [cit. 2021-03-13]. ISSN 0192-0561. DOI 10.1016/0192-0561(91)90120-v. PMID 1726683.
ALSETH, Ingrun; DALHUS, Bjørn; BJØRÅS, Magnar. Inosine in DNA and RNA. Current Opinion in Genetics & Development. 2014-06, roč. 26, s. 116–123. PMID 25173738. Dostupné online [cit. 2021-03-10]. ISSN 1879-0380. DOI 10.1016/j.gde.2014.07.008. PMID 25173738.
MULDOON, R. L.; MEZNY, L.; JACKSON, G. G. Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrobial Agents and Chemotherapy. 1972-09, roč. 2, čís. 3, s. 224–228. PMID 4790561 PMCID: PMC444295. Dostupné online [cit. 2021-03-27]. ISSN 0066-4804. DOI 10.1128/aac.2.3.224. PMID 4790561.
MCCARTHY, Michael T.; LIN, Da; SOGA, Tomoyoshi. Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression. European Journal of Immunology. 2020, roč. 50, čís. 1, s. 130–137. Dostupné online [cit. 2021-03-10]. ISSN 1521-4141. DOI 10.1002/eji.201847948. PMID 31434164. (anglicky)
WALDMAN, R. H.; GANGULY, R. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection. Annals of the New York Academy of Sciences. 1977-03-04, roč. 284, s. 153–160. PMID 81636. Dostupné online [cit. 2021-03-27]. ISSN 0077-8923. DOI 10.1111/j.1749-6632.1977.tb21946.x. PMID 81636.
TSANG, K. Y.; PAN, J. F.; SWANGER, D. L. In vitro restoration of immune responses in aging humans by isoprinosine. International Journal of Immunopharmacology. 1985, roč. 7, čís. 2, s. 199–206. PMID 2409037. Dostupné online [cit. 2021-03-27]. ISSN 0192-0561. DOI 10.1016/0192-0561(85)90027-x. PMID 2409037.
PETROVA, Mihaela; JELEV, Dejan; IVANOVA, Aneta. Isoprinosine affects serum cytokine levels in healthy adults. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research. 2010-04, roč. 30, čís. 4, s. 223–228. PMID 20038210. Dostupné online [cit. 2021-03-10]. ISSN 1557-7465. DOI 10.1089/jir.2009.0057. PMID 20038210.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-03-10]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
LASEK, Witold; JANYST, Michał; WOLNY, Rafał. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharmaceutica (Zagreb, Croatia). 2015-06, roč. 65, čís. 2, s. 171–180. PMID 26011933. Dostupné online [cit. 2021-03-10]. ISSN 1846-9558. DOI 10.1515/acph-2015-0015. PMID 26011933.
MAJEWSKA, Anna; LASEK, Witold; JANYST, Michał. Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro. Central-European Journal of Immunology. 2015, roč. 40, čís. 4, s. 395–399. PMID 26862302 PMCID: PMC4737737. Dostupné online [cit. 2021-03-10]. ISSN 1426-3912. DOI 10.5114/ceji.2015.56960. PMID 26862302.
BERAN, Jiří; ŠALAPOVÁ, Eva; ŠPAJDEL, Marian. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC infectious diseases. 11 07, 2016, roč. 16, čís. 1, s. 648. PMID 27821093 PMCID: PMC5100179. Dostupné online [cit. 2021-03-10]. ISSN 1471-2334. DOI 10.1186/s12879-016-1965-5. PMID 27821093.
RUMEL AHMED, S; NEWMAN, Amy S; O'DALY, James. Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indications. International Immunopharmacology. 2017-01, roč. 42, s. 108–114. Dostupné online [cit. 2021-03-10]. ISSN 1567-5769. DOI 10.1016/j.intimp.2016.11.023.
YOU, Yi; WANG, Li; LI, Yafei. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. The Journal of Dermatology. 2015-06, roč. 42, čís. 6, s. 596–601. PMID 25819042. Dostupné online [cit. 2021-03-13]. ISSN 1346-8138. DOI 10.1111/1346-8138.12845. PMID 25819042.
CTRI/2021/02/030892. A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the defined standard of Care in Covid patients. https://trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/02/030892. 2021-03-31. Dostupné online [cit. 2022-03-16]. DOI 10.1002/central/CN-02241419. (anglicky)
BERAN, Jiří; ŠPAJDEL, Marian; KATZEROVÁ, Věra. Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic. Pathogens. 2020/12, roč. 9, čís. 12, s. 1055. Dostupné online [cit. 2021-03-10]. DOI 10.3390/pathogens9121055. (anglicky)
HAIDUSHKA, I.; ZLATEV, S. ISOPRINOSINE IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. The Lancet. 1987-07, roč. 330, čís. 8551, s. 153. Dostupné online [cit. 2021-04-02]. ISSN 0140-6736. DOI 10.1016/s0140-6736(87)92349-x.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-04-02]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
GALBRAITH, G. M.; THIERS, B. H.; JENSEN, J. A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis. Journal of the American Academy of Dermatology. 1987-05, roč. 16, čís. 5 Pt 1, s. 977–983. PMID 2438319. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(87)70124-8. PMID 2438319.
GALBRAITH, G. M.; THIERS, B. H.; FUDENBERG, H. H. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. Journal of the American Academy of Dermatology. 1984-08, roč. 11, čís. 2 Pt 1, s. 224–230. PMID 6207216. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(84)70153-8. PMID 6207216.
CALTAGIRONE, C.; CARLESIMO, A. Methisoprinol in the treatment of multiple sclerosis. A pilot study. Acta Neurologica Scandinavica. 1986-10, roč. 74, čís. 4, s. 293–296. PMID 2433887. Dostupné online [cit. 2021-04-02]. ISSN 0001-6314. DOI 10.1111/j.1600-0404.1986.tb03517.x. PMID 2433887.
KOLB, H.; GREULICH, B.; KIESEL, U. IMMUNOTHERAPY OF TYPE I DIABETES. The Lancet. 1982-07, roč. 320, čís. 8289, s. 97–98. Dostupné online [cit. 2021-04-02]. ISSN 0140-6736. DOI 10.1016/s0140-6736(82)91715-9.
BRZESKI, M.; MADHOK, R.; HUNTER, J. A. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis. Annals of the Rheumatic Diseases. 1990-05, roč. 49, čís. 5, s. 293–295. PMID 1693065 PMCID: PMC1004071. Dostupné online [cit. 2021-04-02]. ISSN 0003-4967. DOI 10.1136/ard.49.5.293. PMID 1693065.
BERTH-JONES, J.; HUTCHINSON, P. E. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clinical and Experimental Dermatology. 1991-05, roč. 16, čís. 3, s. 172–175. PMID 1718636. Dostupné online [cit. 2021-04-02]. ISSN 0307-6938. DOI 10.1111/j.1365-2230.1991.tb00339.x. PMID 1718636.
MILLIGAN, N. M.; MILLER, D. H.; COMPSTON, D. A. A placebo-controlled trial of isoprinosine in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1994-02, roč. 57, čís. 2, s. 164–168. PMID 7510330 PMCID: PMC1072442. Dostupné online [cit. 2021-04-02]. ISSN 0022-3050. DOI 10.1136/jnnp.57.2.164. PMID 7510330.
CHUCK, A. J.; LLOYD JONES, J. K.; DUNN, N. A. Is inosine pranobex contraindicated in autoimmune disease?. British Medical Journal (Clinical Research Ed.). 1988-02-27, roč. 296, čís. 6622, s. 646. PMID 2450620 PMCID: PMC2545279. Dostupné online [cit. 2021-04-02]. ISSN 0267-0623. DOI 10.1136/bmj.296.6622.646-b. PMID 2450620.
MUTO, Junko; LEE, Hosung; LEE, Hyunjin. Oral administration of inosine produces antidepressant-like effects in mice. Scientific Reports. 2014-02-26, roč. 4, čís. 1, s. 4199. Dostupné online [cit. 2021-03-13]. ISSN 2045-2322. DOI 10.1038/srep04199. (anglicky)

doi.org

CAMPOLI-RICHARDS, Deborah M.; SORKIN, Eugene M.; HEEL, Rennie C. Inosine Pranobex. Drugs. 1986-11-01, roč. 32, čís. 5, s. 383–424. Dostupné online [cit. 2021-03-27]. ISSN 1179-1950. DOI 10.2165/00003495-198632050-00001. (anglicky)

forbes.cz

Forbes: Lék na covid-19? Možná existuje už 50 let, říká známý český vakcinolog, červenec 2020

frekvence1.cz

FREKVENCE1.CZ. Adam Vojtěch: Isoprinosine je lék, který posiluje imunitu. Zabraňuje pouze zhoršení nemoci covid-19 a hospitalizaci. Frekvence 1 [online]. 2020-10-19 [cit. 2021-03-12]. Dostupné online. (anglicky)

google.cz

books.google.cz

EISENBARTH, George S. Immunotherapy of Diabetes and Selected Autoimmune Diseases: Autoimmune 8. [s.l.]: CRC Press 359 s. Dostupné online. ISBN 978-1-351-09034-6. (anglicky) Google-Books-ID: MzWoDwAAQBAJ.

indiatimes.com

economictimes.indiatimes.com

Themis gets Drug Controller’s nod to launch Inosine Pranobex a novel medicine to treat Covid19, A Viral Infection. The Economic Times. Dostupné online [cit. 2022-03-16].

lww.com

journals.lww.com

S. TEGLBJAERG, Lars L.; KROON, Susanne; SANDSTRÖM, Eric. Effect of isoprinosine on HIV antigenaemia. AIDS. 1992-02, roč. 6, čís. 2, s. 199–202. Dostupné online [cit. 2021-03-13]. ISSN 0269-9370. (anglicky)

mdpi.com

BERAN, Jiří; ŠPAJDEL, Marian; KATZEROVÁ, Věra. Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic. Pathogens. 2020/12, roč. 9, čís. 12, s. 1055. Dostupné online [cit. 2021-03-10]. DOI 10.3390/pathogens9121055. (anglicky)

medicaljournals.se

Inosiplex for Treatment of Alopecia Areata: a Randomized Placebo-controlled Study. www.medicaljournals.se [online]. [cit. 2021-03-13]. DOI: 10.2340/00015555-0138. Dostupné online. DOI 10.2340/00015555-0138.

medicines.org.uk

Imunovir 500mg Tablets [online]. UK Electronic Medicines Compendium. Dostupné online.

medikamio.com

GMBH, bitcraft. delimmun 120,25 mg/379,75 mg Tabletten - Gebrauchsinformation. medikamio [online]. [cit. 2021-03-10]. Dostupné online. (německy)

nature.com

MUTO, Junko; LEE, Hosung; LEE, Hyunjin. Oral administration of inosine produces antidepressant-like effects in mice. Scientific Reports. 2014-02-26, roč. 4, čís. 1, s. 4199. Dostupné online [cit. 2021-03-13]. ISSN 2045-2322. DOI 10.1038/srep04199. (anglicky)

neosine.pl

Syrop Neosine Forte. Neosine - Zwalczaj wirusy i nie daj się infekcji [online]. [cit. 2021-03-10]. Dostupné v archivu pořízeném z originálu dne 2021-06-24. (polsky)

nih.gov

ncbi.nlm.nih.gov

SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 08 2019, roč. 36, čís. 8, s. 1878–1905. PMID 31168764 PMCID: PMC6822865. Dostupné online [cit. 2021-03-10]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764.
KOVACS, J. A.; POWELL, F.; VOELLER, D. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.. Antimicrobial Agents and Chemotherapy. 1993-06-01, roč. 37, čís. 6, s. 1227–1231. PMID 7687120. Dostupné online [cit. 2021-03-13]. ISSN 0066-4804. DOI 10.1128/AAC.37.6.1227. PMID 7687120. (anglicky) Archivováno 28. 10. 2020 na Wayback Machine.
DE SIMONE, C.; FAMULARO, G.; TZANTZOGLOU, S. Inosine pranobex in the treatment of HIV infection: a review. International Journal of Immunopharmacology. 1991, roč. 13 Suppl 1, s. 19–27. PMID 1726683. Dostupné online [cit. 2021-03-13]. ISSN 0192-0561. DOI 10.1016/0192-0561(91)90120-v. PMID 1726683.
ALSETH, Ingrun; DALHUS, Bjørn; BJØRÅS, Magnar. Inosine in DNA and RNA. Current Opinion in Genetics & Development. 2014-06, roč. 26, s. 116–123. PMID 25173738. Dostupné online [cit. 2021-03-10]. ISSN 1879-0380. DOI 10.1016/j.gde.2014.07.008. PMID 25173738.
MULDOON, R. L.; MEZNY, L.; JACKSON, G. G. Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrobial Agents and Chemotherapy. 1972-09, roč. 2, čís. 3, s. 224–228. PMID 4790561 PMCID: PMC444295. Dostupné online [cit. 2021-03-27]. ISSN 0066-4804. DOI 10.1128/aac.2.3.224. PMID 4790561.
MCCARTHY, Michael T.; LIN, Da; SOGA, Tomoyoshi. Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression. European Journal of Immunology. 2020, roč. 50, čís. 1, s. 130–137. Dostupné online [cit. 2021-03-10]. ISSN 1521-4141. DOI 10.1002/eji.201847948. PMID 31434164. (anglicky)
WALDMAN, R. H.; GANGULY, R. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection. Annals of the New York Academy of Sciences. 1977-03-04, roč. 284, s. 153–160. PMID 81636. Dostupné online [cit. 2021-03-27]. ISSN 0077-8923. DOI 10.1111/j.1749-6632.1977.tb21946.x. PMID 81636.
TSANG, K. Y.; PAN, J. F.; SWANGER, D. L. In vitro restoration of immune responses in aging humans by isoprinosine. International Journal of Immunopharmacology. 1985, roč. 7, čís. 2, s. 199–206. PMID 2409037. Dostupné online [cit. 2021-03-27]. ISSN 0192-0561. DOI 10.1016/0192-0561(85)90027-x. PMID 2409037.
PETROVA, Mihaela; JELEV, Dejan; IVANOVA, Aneta. Isoprinosine affects serum cytokine levels in healthy adults. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research. 2010-04, roč. 30, čís. 4, s. 223–228. PMID 20038210. Dostupné online [cit. 2021-03-10]. ISSN 1557-7465. DOI 10.1089/jir.2009.0057. PMID 20038210.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-03-10]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
IAKUPOVA, R. Sh; SKACHKOVA, M. A.; CHOLOIAN, S. B. [Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas]. Gigiena I Sanitariia. 2012-05, čís. 3, s. 33–34. PMID 23088120. Dostupné online [cit. 2021-03-21]. ISSN 0016-9900. PMID 23088120.
LASEK, Witold; JANYST, Michał; WOLNY, Rafał. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharmaceutica (Zagreb, Croatia). 2015-06, roč. 65, čís. 2, s. 171–180. PMID 26011933. Dostupné online [cit. 2021-03-10]. ISSN 1846-9558. DOI 10.1515/acph-2015-0015. PMID 26011933.
MAJEWSKA, Anna; LASEK, Witold; JANYST, Michał. Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro. Central-European Journal of Immunology. 2015, roč. 40, čís. 4, s. 395–399. PMID 26862302 PMCID: PMC4737737. Dostupné online [cit. 2021-03-10]. ISSN 1426-3912. DOI 10.5114/ceji.2015.56960. PMID 26862302.
BERAN, Jiří; ŠALAPOVÁ, Eva; ŠPAJDEL, Marian. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC infectious diseases. 11 07, 2016, roč. 16, čís. 1, s. 648. PMID 27821093 PMCID: PMC5100179. Dostupné online [cit. 2021-03-10]. ISSN 1471-2334. DOI 10.1186/s12879-016-1965-5. PMID 27821093.
YOU, Yi; WANG, Li; LI, Yafei. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. The Journal of Dermatology. 2015-06, roč. 42, čís. 6, s. 596–601. PMID 25819042. Dostupné online [cit. 2021-03-13]. ISSN 1346-8138. DOI 10.1111/1346-8138.12845. PMID 25819042.
NAKAMURA, T.; MIYASAKA, N.; POPE, R. M. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases. Clinical and Experimental Immunology. 1983-04, roč. 52, čís. 1, s. 67–74. PMID 6190598 PMCID: PMC1535570. Dostupné online [cit. 2021-04-02]. ISSN 0009-9104. PMID 6190598.
BECKER, H.; LOERS, E.; HELMKE, K. [Therapy of rheumatic diseases with inosiplex]. Immunitat Und Infektion. 1986-05, roč. 14, čís. 3, s. 93–99. PMID 2423433. Dostupné online [cit. 2021-04-02]. PMID 2423433.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-04-02]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
GALBRAITH, G. M.; THIERS, B. H.; JENSEN, J. A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis. Journal of the American Academy of Dermatology. 1987-05, roč. 16, čís. 5 Pt 1, s. 977–983. PMID 2438319. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(87)70124-8. PMID 2438319.
GALBRAITH, G. M.; THIERS, B. H.; FUDENBERG, H. H. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. Journal of the American Academy of Dermatology. 1984-08, roč. 11, čís. 2 Pt 1, s. 224–230. PMID 6207216. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(84)70153-8. PMID 6207216.
CALTAGIRONE, C.; CARLESIMO, A. Methisoprinol in the treatment of multiple sclerosis. A pilot study. Acta Neurologica Scandinavica. 1986-10, roč. 74, čís. 4, s. 293–296. PMID 2433887. Dostupné online [cit. 2021-04-02]. ISSN 0001-6314. DOI 10.1111/j.1600-0404.1986.tb03517.x. PMID 2433887.
FISCHBACH, M.; TALAL, N. Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice. Clinical and Experimental Immunology. 1985-08, roč. 61, čís. 2, s. 242–247. PMID 2412742 PMCID: PMC1577290. Dostupné online [cit. 2021-04-02]. ISSN 0009-9104. PMID 2412742.
WYBRAN, J.; FAMAEY, J. P.; APPELBOOM, T. Inosiplex: a novel treatment in rheumatoid arthritis?. The Journal of Rheumatology. 1981-07, roč. 8, čís. 4, s. 643–646. PMID 6170755. Dostupné online [cit. 2021-04-02]. ISSN 0315-162X. PMID 6170755.
RICEVUTI, G.; MAZZONE, A.; BAIGUERA, R. [Effect of methisoprinol on neutrophil functions in patients with rheumatoid arthritis]. Minerva Medica. 1985-10-27, roč. 76, čís. 41, s. 1945–1950. PMID 2414688. Dostupné online [cit. 2021-04-02]. ISSN 0026-4806. PMID 2414688.
MAZZONE, A.; BAIGURA, R.; ROSSINI, S. Immunomodulation of neutrophil chemotaxis in rheumatoid arthritis using levamisole and methisoprinol. Clinical Therapeutics. 1986, roč. 8, čís. 2, s. 232–237. PMID 2421905. Dostupné online [cit. 2021-04-02]. ISSN 0149-2918. PMID 2421905.
JURYŃCZYK, J.; JURKOWSKI, A.; JEDRZEJCZAK-SODULSKA, B. [A case of Steel-Richardson-Olszewski syndrome]. Neurologia I Neurochirurgia Polska. 1990-01, roč. 24, čís. 1–2, s. 90–93. PMID 1720223. Dostupné online [cit. 2021-04-02]. ISSN 0028-3843. PMID 1720223.
SÁNCHEZ PALACIOS, A.; QUINTERO, A.; CLAVERO GARÍN, A. Immunoregulation with methisoprinol in Sjögren's syndrome. Allergologia Et Immunopathologia. 1986-01, roč. 14, čís. 1, s. 21–29. PMID 2421565. Dostupné online [cit. 2021-04-02]. ISSN 0301-0546. PMID 2421565.
BRZESKI, M.; MADHOK, R.; HUNTER, J. A. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis. Annals of the Rheumatic Diseases. 1990-05, roč. 49, čís. 5, s. 293–295. PMID 1693065 PMCID: PMC1004071. Dostupné online [cit. 2021-04-02]. ISSN 0003-4967. DOI 10.1136/ard.49.5.293. PMID 1693065.
BOUVIER, M.; BONVOISIN, B.; LEJEUNE, E. [Treatment of rheumatoid arthritis with isoprinosine. Personal experience]. Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires. 1983-10, roč. 50, čís. 10, s. 653–657. PMID 6196834. Dostupné online [cit. 2021-04-02]. ISSN 0035-2659. PMID 6196834.
BERTH-JONES, J.; HUTCHINSON, P. E. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clinical and Experimental Dermatology. 1991-05, roč. 16, čís. 3, s. 172–175. PMID 1718636. Dostupné online [cit. 2021-04-02]. ISSN 0307-6938. DOI 10.1111/j.1365-2230.1991.tb00339.x. PMID 1718636.
MILLIGAN, N. M.; MILLER, D. H.; COMPSTON, D. A. A placebo-controlled trial of isoprinosine in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1994-02, roč. 57, čís. 2, s. 164–168. PMID 7510330 PMCID: PMC1072442. Dostupné online [cit. 2021-04-02]. ISSN 0022-3050. DOI 10.1136/jnnp.57.2.164. PMID 7510330.
MIROUZE, J.; RODIER, M.; RICHARD, J. L. Trial of mild immunosuppression by methisoprinol in acute onset diabetes mellitus: effects on rate and duration of remission. Diabetes Research (Edinburgh, Scotland). 1986-09, roč. 3, čís. 7, s. 359–362. PMID 2430750. Dostupné online [cit. 2021-04-02]. ISSN 0265-5985. PMID 2430750.
CHUCK, A. J.; LLOYD JONES, J. K.; DUNN, N. A. Is inosine pranobex contraindicated in autoimmune disease?. British Medical Journal (Clinical Research Ed.). 1988-02-27, roč. 296, čís. 6622, s. 646. PMID 2450620 PMCID: PMC2545279. Dostupné online [cit. 2021-04-02]. ISSN 0267-0623. DOI 10.1136/bmj.296.6622.646-b. PMID 2450620.

pubmed.ncbi.nlm.nih.gov

SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 08 2019, roč. 36, čís. 8, s. 1878–1905. PMID 31168764 PMCID: PMC6822865. Dostupné online [cit. 2021-03-10]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764.
DE SIMONE, C.; FAMULARO, G.; TZANTZOGLOU, S. Inosine pranobex in the treatment of HIV infection: a review. International Journal of Immunopharmacology. 1991, roč. 13 Suppl 1, s. 19–27. PMID 1726683. Dostupné online [cit. 2021-03-13]. ISSN 0192-0561. DOI 10.1016/0192-0561(91)90120-v. PMID 1726683.
ALSETH, Ingrun; DALHUS, Bjørn; BJØRÅS, Magnar. Inosine in DNA and RNA. Current Opinion in Genetics & Development. 2014-06, roč. 26, s. 116–123. PMID 25173738. Dostupné online [cit. 2021-03-10]. ISSN 1879-0380. DOI 10.1016/j.gde.2014.07.008. PMID 25173738.
MULDOON, R. L.; MEZNY, L.; JACKSON, G. G. Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrobial Agents and Chemotherapy. 1972-09, roč. 2, čís. 3, s. 224–228. PMID 4790561 PMCID: PMC444295. Dostupné online [cit. 2021-03-27]. ISSN 0066-4804. DOI 10.1128/aac.2.3.224. PMID 4790561.
WALDMAN, R. H.; GANGULY, R. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection. Annals of the New York Academy of Sciences. 1977-03-04, roč. 284, s. 153–160. PMID 81636. Dostupné online [cit. 2021-03-27]. ISSN 0077-8923. DOI 10.1111/j.1749-6632.1977.tb21946.x. PMID 81636.
TSANG, K. Y.; PAN, J. F.; SWANGER, D. L. In vitro restoration of immune responses in aging humans by isoprinosine. International Journal of Immunopharmacology. 1985, roč. 7, čís. 2, s. 199–206. PMID 2409037. Dostupné online [cit. 2021-03-27]. ISSN 0192-0561. DOI 10.1016/0192-0561(85)90027-x. PMID 2409037.
PETROVA, Mihaela; JELEV, Dejan; IVANOVA, Aneta. Isoprinosine affects serum cytokine levels in healthy adults. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research. 2010-04, roč. 30, čís. 4, s. 223–228. PMID 20038210. Dostupné online [cit. 2021-03-10]. ISSN 1557-7465. DOI 10.1089/jir.2009.0057. PMID 20038210.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-03-10]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
IAKUPOVA, R. Sh; SKACHKOVA, M. A.; CHOLOIAN, S. B. [Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas]. Gigiena I Sanitariia. 2012-05, čís. 3, s. 33–34. PMID 23088120. Dostupné online [cit. 2021-03-21]. ISSN 0016-9900. PMID 23088120.
LASEK, Witold; JANYST, Michał; WOLNY, Rafał. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharmaceutica (Zagreb, Croatia). 2015-06, roč. 65, čís. 2, s. 171–180. PMID 26011933. Dostupné online [cit. 2021-03-10]. ISSN 1846-9558. DOI 10.1515/acph-2015-0015. PMID 26011933.
BERAN, Jiří; ŠALAPOVÁ, Eva; ŠPAJDEL, Marian. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC infectious diseases. 11 07, 2016, roč. 16, čís. 1, s. 648. PMID 27821093 PMCID: PMC5100179. Dostupné online [cit. 2021-03-10]. ISSN 1471-2334. DOI 10.1186/s12879-016-1965-5. PMID 27821093.
YOU, Yi; WANG, Li; LI, Yafei. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. The Journal of Dermatology. 2015-06, roč. 42, čís. 6, s. 596–601. PMID 25819042. Dostupné online [cit. 2021-03-13]. ISSN 1346-8138. DOI 10.1111/1346-8138.12845. PMID 25819042.
NAKAMURA, T.; MIYASAKA, N.; POPE, R. M. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases. Clinical and Experimental Immunology. 1983-04, roč. 52, čís. 1, s. 67–74. PMID 6190598 PMCID: PMC1535570. Dostupné online [cit. 2021-04-02]. ISSN 0009-9104. PMID 6190598.
BECKER, H.; LOERS, E.; HELMKE, K. [Therapy of rheumatic diseases with inosiplex]. Immunitat Und Infektion. 1986-05, roč. 14, čís. 3, s. 93–99. PMID 2423433. Dostupné online [cit. 2021-04-02]. PMID 2423433.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-04-02]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
GALBRAITH, G. M.; THIERS, B. H.; JENSEN, J. A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis. Journal of the American Academy of Dermatology. 1987-05, roč. 16, čís. 5 Pt 1, s. 977–983. PMID 2438319. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(87)70124-8. PMID 2438319.
GALBRAITH, G. M.; THIERS, B. H.; FUDENBERG, H. H. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. Journal of the American Academy of Dermatology. 1984-08, roč. 11, čís. 2 Pt 1, s. 224–230. PMID 6207216. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(84)70153-8. PMID 6207216.
CALTAGIRONE, C.; CARLESIMO, A. Methisoprinol in the treatment of multiple sclerosis. A pilot study. Acta Neurologica Scandinavica. 1986-10, roč. 74, čís. 4, s. 293–296. PMID 2433887. Dostupné online [cit. 2021-04-02]. ISSN 0001-6314. DOI 10.1111/j.1600-0404.1986.tb03517.x. PMID 2433887.
FISCHBACH, M.; TALAL, N. Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice. Clinical and Experimental Immunology. 1985-08, roč. 61, čís. 2, s. 242–247. PMID 2412742 PMCID: PMC1577290. Dostupné online [cit. 2021-04-02]. ISSN 0009-9104. PMID 2412742.
WYBRAN, J.; FAMAEY, J. P.; APPELBOOM, T. Inosiplex: a novel treatment in rheumatoid arthritis?. The Journal of Rheumatology. 1981-07, roč. 8, čís. 4, s. 643–646. PMID 6170755. Dostupné online [cit. 2021-04-02]. ISSN 0315-162X. PMID 6170755.
RICEVUTI, G.; MAZZONE, A.; BAIGUERA, R. [Effect of methisoprinol on neutrophil functions in patients with rheumatoid arthritis]. Minerva Medica. 1985-10-27, roč. 76, čís. 41, s. 1945–1950. PMID 2414688. Dostupné online [cit. 2021-04-02]. ISSN 0026-4806. PMID 2414688.
MAZZONE, A.; BAIGURA, R.; ROSSINI, S. Immunomodulation of neutrophil chemotaxis in rheumatoid arthritis using levamisole and methisoprinol. Clinical Therapeutics. 1986, roč. 8, čís. 2, s. 232–237. PMID 2421905. Dostupné online [cit. 2021-04-02]. ISSN 0149-2918. PMID 2421905.
JURYŃCZYK, J.; JURKOWSKI, A.; JEDRZEJCZAK-SODULSKA, B. [A case of Steel-Richardson-Olszewski syndrome]. Neurologia I Neurochirurgia Polska. 1990-01, roč. 24, čís. 1–2, s. 90–93. PMID 1720223. Dostupné online [cit. 2021-04-02]. ISSN 0028-3843. PMID 1720223.
SÁNCHEZ PALACIOS, A.; QUINTERO, A.; CLAVERO GARÍN, A. Immunoregulation with methisoprinol in Sjögren's syndrome. Allergologia Et Immunopathologia. 1986-01, roč. 14, čís. 1, s. 21–29. PMID 2421565. Dostupné online [cit. 2021-04-02]. ISSN 0301-0546. PMID 2421565.
BRZESKI, M.; MADHOK, R.; HUNTER, J. A. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis. Annals of the Rheumatic Diseases. 1990-05, roč. 49, čís. 5, s. 293–295. PMID 1693065 PMCID: PMC1004071. Dostupné online [cit. 2021-04-02]. ISSN 0003-4967. DOI 10.1136/ard.49.5.293. PMID 1693065.
BOUVIER, M.; BONVOISIN, B.; LEJEUNE, E. [Treatment of rheumatoid arthritis with isoprinosine. Personal experience]. Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires. 1983-10, roč. 50, čís. 10, s. 653–657. PMID 6196834. Dostupné online [cit. 2021-04-02]. ISSN 0035-2659. PMID 6196834.
BERTH-JONES, J.; HUTCHINSON, P. E. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clinical and Experimental Dermatology. 1991-05, roč. 16, čís. 3, s. 172–175. PMID 1718636. Dostupné online [cit. 2021-04-02]. ISSN 0307-6938. DOI 10.1111/j.1365-2230.1991.tb00339.x. PMID 1718636.
MILLIGAN, N. M.; MILLER, D. H.; COMPSTON, D. A. A placebo-controlled trial of isoprinosine in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1994-02, roč. 57, čís. 2, s. 164–168. PMID 7510330 PMCID: PMC1072442. Dostupné online [cit. 2021-04-02]. ISSN 0022-3050. DOI 10.1136/jnnp.57.2.164. PMID 7510330.
MIROUZE, J.; RODIER, M.; RICHARD, J. L. Trial of mild immunosuppression by methisoprinol in acute onset diabetes mellitus: effects on rate and duration of remission. Diabetes Research (Edinburgh, Scotland). 1986-09, roč. 3, čís. 7, s. 359–362. PMID 2430750. Dostupné online [cit. 2021-04-02]. ISSN 0265-5985. PMID 2430750.
CHUCK, A. J.; LLOYD JONES, J. K.; DUNN, N. A. Is inosine pranobex contraindicated in autoimmune disease?. British Medical Journal (Clinical Research Ed.). 1988-02-27, roč. 296, čís. 6622, s. 646. PMID 2450620 PMCID: PMC2545279. Dostupné online [cit. 2021-04-02]. ISSN 0267-0623. DOI 10.1136/bmj.296.6622.646-b. PMID 2450620.

pubchem.ncbi.nlm.nih.gov

PUBCHEM. Inosine pranobex. pubchem.ncbi.nlm.nih.gov [online]. [cit. 2021-03-10]. Dostupné online. (anglicky)

ockovacicentrum.cz

TKADLECOVÁ, Hana. Léčba viru Covid-19. www.ockovacicentrum.cz [online]. Avenier [cit. 2021-03-12]. Dostupné online.

oncologia.mx

Oncologia.mx [online]. 2020-09-14 [cit. 2021-03-27]. Dostupné online. (španělsky)

patents.google.com

Complex of inosine with dialkyl-aminoalkanol. USA. Patentový spis US3646007A. 1969-08-28. Dostupné: <online> [cit. 2021-03-10]. (anglicky)

petice.com

PETICE PRO ZAJIŠTĚNÍ DOSTATEČNÉHO MNOŽSTVÍ A VOLNÉHO PRODEJE LÉKU ISOPRINOSINE. Petice.com [online]. [cit. 2021-03-10]. Dostupné online.

practicus.eu

SEIFERT, Bohumil; BALÍK, Martin; BÁRTŮ, Václava. Optimalizace klinických přístupů k pacientům s onemocněním COVID-19 v primární péči. Practicus. Roč. 20, čís. 8, s. 18–23. Dostupné online.
HUTAŘ, Ivan. ISOPRINOSINE (inosin pranobex) a jeho uplatnění v praxi praktického lékaře – mechanismy účinku, dávkování. Practicus. 26.4.2021, roč. 20, čís. 4, s. 27–28. Dostupné online.
MACHÁČ, Jan. Otevřený dopis. Practicus. 26.4.2021, roč. 20, čís. 4, s. 30. Dostupné online.

precisionvaccinations.com

COVID-19 Treatments For 2022. www.precisionvaccinations.com [online]. [cit. 2022-03-16]. Dostupné v archivu pořízeném z originálu dne 2022-04-01. (anglicky)

prolekare.cz

WWW.MEDITORIAL.CZ. Největší informační zdroj pro lékaře - proLékaře.cz. www.prolekare.cz [online]. [cit. 2021-03-12]. Dostupné online.

remedia.cz

Remedia – farmakoterapeutický časopis. www.remedia.cz [online]. [cit. 2021-03-10]. Dostupné online.

sukl.cz

ISOPRINOSINE, 500MG TBL NOB 100, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2021-03-10]. Dostupné online.
S.R.O., QCM. SÚKL o sběru dat k inosin pranobexu v domovech důchodců, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2021-03-10]. Dostupné online.

theprint.in

DCGI approves Themis Medicare's VIRALEX®[?] for Covid-19 treatment [online]. 2022-03-05 [cit. 2022-03-16]. Dostupné online. (anglicky)

tribune.cz

WWW.BENES-MICHL.CZ, Beneš & Michl. Fórum: Jak a čím léčit COVID‑19? | MT. www.tribune.cz [online]. [cit. 2022-01-06]. Dostupné online.
MEDICAL TRIBUNE CZ > Inosin pranobex u akutních respiračních onemocnění - Review. www.tribune.cz [online]. [cit. 2021-03-17]. Dostupné online.

web.archive.org

AMERICAN CANCER SOCIETY. Inosine Pranobex [online]. [cit. 2013-07-31]. Dostupné v archivu pořízeném z originálu dne 23 August 2010.
Inosine Pranobex. web.archive.org [online]. 2010-08-23 [cit. 2021-03-13]. Dostupné v archivu pořízeném z originálu dne 2010-08-23.
Winners – Galien Foundation [online]. [cit. 2021-03-10]. Dostupné v archivu pořízeném dne 2021-04-10. (anglicky)
Syrop Neosine Forte. Neosine - Zwalczaj wirusy i nie daj się infekcji [online]. [cit. 2021-03-10]. Dostupné v archivu pořízeném z originálu dne 2021-06-24. (polsky)
KOVACS, J. A.; POWELL, F.; VOELLER, D. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.. Antimicrobial Agents and Chemotherapy. 1993-06-01, roč. 37, čís. 6, s. 1227–1231. PMID 7687120. Dostupné online [cit. 2021-03-13]. ISSN 0066-4804. DOI 10.1128/AAC.37.6.1227. PMID 7687120. (anglicky) Archivováno 28. 10. 2020 na Wayback Machine.
COVID-19 Treatments For 2022. www.precisionvaccinations.com [online]. [cit. 2022-03-16]. Dostupné v archivu pořízeném z originálu dne 2022-04-01. (anglicky)
KÜMPEL, Petr; HOLUB, Michal. Doporučený postup SIL ČLS JEP léčby pacientů s onemocněním covid-19 [online]. Společnost infekčního lékařství ČLS JEP, 4. 12. 2020 [cit. 2021-03-10]. Dostupné v archivu pořízeném dne 2021-01-18.
ČERNÁ-PAŘÍZKOVÁ, Ranata. Péče o hospitalizované pacienty s COVID-19 - Doporučený postup FN HK [online]. Fakultní nemocnice Hradec Králové, Verze 2 - 18.11.2020 [cit. 2021-03-10]. Dostupné v archivu pořízeném dne 2021-04-13.

who.int

trialsearch.who.int

CTRI/2021/02/030892. A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the defined standard of Care in Covid patients. https://trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/02/030892. 2021-03-31. Dostupné online [cit. 2022-03-16]. DOI 10.1002/central/CN-02241419. (anglicky)

wiley.com

onlinelibrary.wiley.com

MCCARTHY, Michael T.; LIN, Da; SOGA, Tomoyoshi. Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression. European Journal of Immunology. 2020, roč. 50, čís. 1, s. 130–137. Dostupné online [cit. 2021-03-10]. ISSN 1521-4141. DOI 10.1002/eji.201847948. PMID 31434164. (anglicky)

worldcat.org

KREJSEK, Jan. Imunologie člověka. 1. vydání. vyd. Hradec Králové: [s.n.] 495 s. Dostupné online. ISBN 978-80-86472-74-4, ISBN 80-86472-74-4. OCLC 982100822
CAMPOLI-RICHARDS, Deborah M.; SORKIN, Eugene M.; HEEL, Rennie C. Inosine Pranobex. Drugs. 1986-11-01, roč. 32, čís. 5, s. 383–424. Dostupné online [cit. 2021-03-27]. ISSN 1179-1950. DOI 10.2165/00003495-198632050-00001. (anglicky)
SLIVA, Jiri; PANTZARTZI, Chrysoula N.; VOTAVA, Martin. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. Advances in Therapy. 08 2019, roč. 36, čís. 8, s. 1878–1905. PMID 31168764 PMCID: PMC6822865. Dostupné online [cit. 2021-03-10]. ISSN 1865-8652. DOI 10.1007/s12325-019-00995-6. PMID 31168764.
KOVACS, J. A.; POWELL, F.; VOELLER, D. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.. Antimicrobial Agents and Chemotherapy. 1993-06-01, roč. 37, čís. 6, s. 1227–1231. PMID 7687120. Dostupné online [cit. 2021-03-13]. ISSN 0066-4804. DOI 10.1128/AAC.37.6.1227. PMID 7687120. (anglicky) Archivováno 28. 10. 2020 na Wayback Machine.
S. TEGLBJAERG, Lars L.; KROON, Susanne; SANDSTRÖM, Eric. Effect of isoprinosine on HIV antigenaemia. AIDS. 1992-02, roč. 6, čís. 2, s. 199–202. Dostupné online [cit. 2021-03-13]. ISSN 0269-9370. (anglicky)
DE SIMONE, C.; FAMULARO, G.; TZANTZOGLOU, S. Inosine pranobex in the treatment of HIV infection: a review. International Journal of Immunopharmacology. 1991, roč. 13 Suppl 1, s. 19–27. PMID 1726683. Dostupné online [cit. 2021-03-13]. ISSN 0192-0561. DOI 10.1016/0192-0561(91)90120-v. PMID 1726683.
ALSETH, Ingrun; DALHUS, Bjørn; BJØRÅS, Magnar. Inosine in DNA and RNA. Current Opinion in Genetics & Development. 2014-06, roč. 26, s. 116–123. PMID 25173738. Dostupné online [cit. 2021-03-10]. ISSN 1879-0380. DOI 10.1016/j.gde.2014.07.008. PMID 25173738.
MULDOON, R. L.; MEZNY, L.; JACKSON, G. G. Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrobial Agents and Chemotherapy. 1972-09, roč. 2, čís. 3, s. 224–228. PMID 4790561 PMCID: PMC444295. Dostupné online [cit. 2021-03-27]. ISSN 0066-4804. DOI 10.1128/aac.2.3.224. PMID 4790561.
MCCARTHY, Michael T.; LIN, Da; SOGA, Tomoyoshi. Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression. European Journal of Immunology. 2020, roč. 50, čís. 1, s. 130–137. Dostupné online [cit. 2021-03-10]. ISSN 1521-4141. DOI 10.1002/eji.201847948. PMID 31434164. (anglicky)
WALDMAN, R. H.; GANGULY, R. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection. Annals of the New York Academy of Sciences. 1977-03-04, roč. 284, s. 153–160. PMID 81636. Dostupné online [cit. 2021-03-27]. ISSN 0077-8923. DOI 10.1111/j.1749-6632.1977.tb21946.x. PMID 81636.
TSANG, K. Y.; PAN, J. F.; SWANGER, D. L. In vitro restoration of immune responses in aging humans by isoprinosine. International Journal of Immunopharmacology. 1985, roč. 7, čís. 2, s. 199–206. PMID 2409037. Dostupné online [cit. 2021-03-27]. ISSN 0192-0561. DOI 10.1016/0192-0561(85)90027-x. PMID 2409037.
PETROVA, Mihaela; JELEV, Dejan; IVANOVA, Aneta. Isoprinosine affects serum cytokine levels in healthy adults. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research. 2010-04, roč. 30, čís. 4, s. 223–228. PMID 20038210. Dostupné online [cit. 2021-03-10]. ISSN 1557-7465. DOI 10.1089/jir.2009.0057. PMID 20038210.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-03-10]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
IAKUPOVA, R. Sh; SKACHKOVA, M. A.; CHOLOIAN, S. B. [Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas]. Gigiena I Sanitariia. 2012-05, čís. 3, s. 33–34. PMID 23088120. Dostupné online [cit. 2021-03-21]. ISSN 0016-9900. PMID 23088120.
LASEK, Witold; JANYST, Michał; WOLNY, Rafał. Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharmaceutica (Zagreb, Croatia). 2015-06, roč. 65, čís. 2, s. 171–180. PMID 26011933. Dostupné online [cit. 2021-03-10]. ISSN 1846-9558. DOI 10.1515/acph-2015-0015. PMID 26011933.
MAJEWSKA, Anna; LASEK, Witold; JANYST, Michał. Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro. Central-European Journal of Immunology. 2015, roč. 40, čís. 4, s. 395–399. PMID 26862302 PMCID: PMC4737737. Dostupné online [cit. 2021-03-10]. ISSN 1426-3912. DOI 10.5114/ceji.2015.56960. PMID 26862302.
BERAN, Jiří; ŠALAPOVÁ, Eva; ŠPAJDEL, Marian. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC infectious diseases. 11 07, 2016, roč. 16, čís. 1, s. 648. PMID 27821093 PMCID: PMC5100179. Dostupné online [cit. 2021-03-10]. ISSN 1471-2334. DOI 10.1186/s12879-016-1965-5. PMID 27821093.
RUMEL AHMED, S; NEWMAN, Amy S; O'DALY, James. Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indications. International Immunopharmacology. 2017-01, roč. 42, s. 108–114. Dostupné online [cit. 2021-03-10]. ISSN 1567-5769. DOI 10.1016/j.intimp.2016.11.023.
YOU, Yi; WANG, Li; LI, Yafei. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. The Journal of Dermatology. 2015-06, roč. 42, čís. 6, s. 596–601. PMID 25819042. Dostupné online [cit. 2021-03-13]. ISSN 1346-8138. DOI 10.1111/1346-8138.12845. PMID 25819042.
NAKAMURA, T.; MIYASAKA, N.; POPE, R. M. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases. Clinical and Experimental Immunology. 1983-04, roč. 52, čís. 1, s. 67–74. PMID 6190598 PMCID: PMC1535570. Dostupné online [cit. 2021-04-02]. ISSN 0009-9104. PMID 6190598.
HAIDUSHKA, I.; ZLATEV, S. ISOPRINOSINE IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. The Lancet. 1987-07, roč. 330, čís. 8551, s. 153. Dostupné online [cit. 2021-04-02]. ISSN 0140-6736. DOI 10.1016/s0140-6736(87)92349-x.
GEORGALA, Sofia; KATOULIS, Alexander C.; BEFON, Angeliki. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study. Acta Dermato-Venereologica. 2006, roč. 86, čís. 5, s. 422–424. PMID 16955187. Dostupné online [cit. 2021-04-02]. ISSN 0001-5555. DOI 10.2340/00015555-0138. PMID 16955187.
GALBRAITH, G. M.; THIERS, B. H.; JENSEN, J. A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis. Journal of the American Academy of Dermatology. 1987-05, roč. 16, čís. 5 Pt 1, s. 977–983. PMID 2438319. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(87)70124-8. PMID 2438319.
GALBRAITH, G. M.; THIERS, B. H.; FUDENBERG, H. H. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. Journal of the American Academy of Dermatology. 1984-08, roč. 11, čís. 2 Pt 1, s. 224–230. PMID 6207216. Dostupné online [cit. 2021-04-02]. ISSN 0190-9622. DOI 10.1016/s0190-9622(84)70153-8. PMID 6207216.
CALTAGIRONE, C.; CARLESIMO, A. Methisoprinol in the treatment of multiple sclerosis. A pilot study. Acta Neurologica Scandinavica. 1986-10, roč. 74, čís. 4, s. 293–296. PMID 2433887. Dostupné online [cit. 2021-04-02]. ISSN 0001-6314. DOI 10.1111/j.1600-0404.1986.tb03517.x. PMID 2433887.
FISCHBACH, M.; TALAL, N. Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice. Clinical and Experimental Immunology. 1985-08, roč. 61, čís. 2, s. 242–247. PMID 2412742 PMCID: PMC1577290. Dostupné online [cit. 2021-04-02]. ISSN 0009-9104. PMID 2412742.
WYBRAN, J.; FAMAEY, J. P.; APPELBOOM, T. Inosiplex: a novel treatment in rheumatoid arthritis?. The Journal of Rheumatology. 1981-07, roč. 8, čís. 4, s. 643–646. PMID 6170755. Dostupné online [cit. 2021-04-02]. ISSN 0315-162X. PMID 6170755.
RICEVUTI, G.; MAZZONE, A.; BAIGUERA, R. [Effect of methisoprinol on neutrophil functions in patients with rheumatoid arthritis]. Minerva Medica. 1985-10-27, roč. 76, čís. 41, s. 1945–1950. PMID 2414688. Dostupné online [cit. 2021-04-02]. ISSN 0026-4806. PMID 2414688.
MAZZONE, A.; BAIGURA, R.; ROSSINI, S. Immunomodulation of neutrophil chemotaxis in rheumatoid arthritis using levamisole and methisoprinol. Clinical Therapeutics. 1986, roč. 8, čís. 2, s. 232–237. PMID 2421905. Dostupné online [cit. 2021-04-02]. ISSN 0149-2918. PMID 2421905.
JURYŃCZYK, J.; JURKOWSKI, A.; JEDRZEJCZAK-SODULSKA, B. [A case of Steel-Richardson-Olszewski syndrome]. Neurologia I Neurochirurgia Polska. 1990-01, roč. 24, čís. 1–2, s. 90–93. PMID 1720223. Dostupné online [cit. 2021-04-02]. ISSN 0028-3843. PMID 1720223.
SÁNCHEZ PALACIOS, A.; QUINTERO, A.; CLAVERO GARÍN, A. Immunoregulation with methisoprinol in Sjögren's syndrome. Allergologia Et Immunopathologia. 1986-01, roč. 14, čís. 1, s. 21–29. PMID 2421565. Dostupné online [cit. 2021-04-02]. ISSN 0301-0546. PMID 2421565.
KOLB, H.; GREULICH, B.; KIESEL, U. IMMUNOTHERAPY OF TYPE I DIABETES. The Lancet. 1982-07, roč. 320, čís. 8289, s. 97–98. Dostupné online [cit. 2021-04-02]. ISSN 0140-6736. DOI 10.1016/s0140-6736(82)91715-9.
BRZESKI, M.; MADHOK, R.; HUNTER, J. A. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis. Annals of the Rheumatic Diseases. 1990-05, roč. 49, čís. 5, s. 293–295. PMID 1693065 PMCID: PMC1004071. Dostupné online [cit. 2021-04-02]. ISSN 0003-4967. DOI 10.1136/ard.49.5.293. PMID 1693065.
BOUVIER, M.; BONVOISIN, B.; LEJEUNE, E. [Treatment of rheumatoid arthritis with isoprinosine. Personal experience]. Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires. 1983-10, roč. 50, čís. 10, s. 653–657. PMID 6196834. Dostupné online [cit. 2021-04-02]. ISSN 0035-2659. PMID 6196834.
BERTH-JONES, J.; HUTCHINSON, P. E. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clinical and Experimental Dermatology. 1991-05, roč. 16, čís. 3, s. 172–175. PMID 1718636. Dostupné online [cit. 2021-04-02]. ISSN 0307-6938. DOI 10.1111/j.1365-2230.1991.tb00339.x. PMID 1718636.
MILLIGAN, N. M.; MILLER, D. H.; COMPSTON, D. A. A placebo-controlled trial of isoprinosine in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1994-02, roč. 57, čís. 2, s. 164–168. PMID 7510330 PMCID: PMC1072442. Dostupné online [cit. 2021-04-02]. ISSN 0022-3050. DOI 10.1136/jnnp.57.2.164. PMID 7510330.
MIROUZE, J.; RODIER, M.; RICHARD, J. L. Trial of mild immunosuppression by methisoprinol in acute onset diabetes mellitus: effects on rate and duration of remission. Diabetes Research (Edinburgh, Scotland). 1986-09, roč. 3, čís. 7, s. 359–362. PMID 2430750. Dostupné online [cit. 2021-04-02]. ISSN 0265-5985. PMID 2430750.
CHUCK, A. J.; LLOYD JONES, J. K.; DUNN, N. A. Is inosine pranobex contraindicated in autoimmune disease?. British Medical Journal (Clinical Research Ed.). 1988-02-27, roč. 296, čís. 6622, s. 646. PMID 2450620 PMCID: PMC2545279. Dostupné online [cit. 2021-04-02]. ISSN 0267-0623. DOI 10.1136/bmj.296.6622.646-b. PMID 2450620.
BARTŮŇKOVÁ, Jiřina. Imunodeficience. 2., přeprac. a dopl. vyd. vyd. Praha: Grada 254 s., [4] s. barev. obr. příl. s. Dostupné online. ISBN 978-80-247-1980-1, ISBN 80-247-1980-0. OCLC 124088004
MUTO, Junko; LEE, Hosung; LEE, Hyunjin. Oral administration of inosine produces antidepressant-like effects in mice. Scientific Reports. 2014-02-26, roč. 4, čís. 1, s. 4199. Dostupné online [cit. 2021-03-13]. ISSN 2045-2322. DOI 10.1038/srep04199. (anglicky)

zdravotnickydenik.cz

Zdravotnický deník: Isoprinosine není zázračným lékem proti covid-19. Jeho českou studii provází vážná odborná i etická pochybení, 17.1.2021